ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Superioroboe2
|
1.0K |
416K |
33 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
Superioroboe2
|
102 |
21K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
102
|
21K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Superioroboe2
|
154 |
49K |
8 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
154
|
49K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Superioroboe2
|
154 |
49K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
154
|
49K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Superioroboe2
|
154 |
49K |
18 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
154
|
49K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Superioroboe2
|
549 |
179K |
15 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
179K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Superioroboe2
|
9.8K |
2.9M |
17 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Superioroboe2
|
716 |
202K |
3 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
716
|
202K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast CC Transcript 31/8
|
|
Superioroboe2
|
73 |
30K |
11 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
73
|
30K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Superioroboe2
|
1.0K |
399K |
9 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Superioroboe2
|
1.3K |
554K |
44 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
554K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Superioroboe2
|
1.0K |
391K |
41 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Superioroboe2
|
905 |
286K |
4 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
905
|
286K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
Superioroboe2
|
618 |
238K |
11 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
618
|
238K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Superioroboe2
|
355 |
96K |
7 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
355
|
96K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Superioroboe2
|
355 |
96K |
7 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
355
|
96K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Superioroboe2
|
4.7K |
1.1M |
1 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
1
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
Superioroboe2
|
248 |
105K |
8 |
10/10/22 |
10/10/22 |
Charts
|
248
|
105K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Superioroboe2
|
576 |
205K |
35 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
205K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Time is coming
|
|
Superioroboe2
|
252 |
89K |
19 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
252
|
89K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
Superioroboe2
|
321 |
103K |
27 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
103K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Superioroboe2
|
256 |
108K |
26 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
256
|
108K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Superioroboe2
|
211 |
73K |
21 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
73K
|
21
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ completes successful placement of $75 million
|
|
Superioroboe2
|
312 |
130K |
10 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
312
|
130K
|
10
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Cornerstone investor secured for Manono Project
|
|
Superioroboe2
|
347 |
169K |
9 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
347
|
169K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Why has Novartis taken down the MSB media release from their website?
|
|
Superioroboe2
|
28 |
11K |
11 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
28
|
11K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
This is what PWC (their auditor said today)
|
|
Superioroboe2
|
78 |
19K |
8 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
78
|
19K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
Superioroboe2
|
508 |
172K |
16 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
172K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
AGM Discussion
|
|
Superioroboe2
|
254 |
100K |
22 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
254
|
100K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
Superioroboe2
|
811 |
334K |
3 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
811
|
334K
|
3
|
|